✅ New CEO and Officers(8/23) ✅ Market Cap Only ~2.8m ✅ Secured a $1M line of credit: Non-Dilutive ✅ Filings: Pink Current ✅ Strong Inside Ownership ~90% ✅ ~400m Float ✅ Updates in the Pipeline - Steady updates/news ✅ 1.6B Shares Retired and reduced its preferred classes to three. ✅ 1.5B Reduction in Authorized Share Count ✅ No Convertible Notes ✅ Name and Symbol Change Coming! (Royal Biotek) ✅ Chart coming off solid bottom and 52-week low ✅ Recent acquisitions increasing revenues ✅ CEO Strengthening Shareholder Value ✅ CEO Affirms No Reverse Split (past split was with old management) ✅ Expansion of Florida facility to nearly 11,000 square feet. ✅ 2022 Revenues Surpass 2021 by Over 335%